WebGreenwich LifeSciences. Greenwich LifeSciences (Nasdaq: GLSI) is a public clinical-stage biopharmaceutical company focused on the development of an immunotherapy to … WebGreenwich LifeSciences is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery.
Greenwich LifeSciences Inc (GLSI) Stock Price Today, …
WebApr 14, 2024 · Whilst it may not be a huge deal, we thought it was good to see that the Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO, CFO & Director, Snehal Patel, … WebApr 6, 2024 · Greenwich LifeSciences, Inc. (GLSI) Stock Price Today, Quote & News Seeking Alpha Is GLSI a Buy? Find out with Premium for only $4.95 » GLSI Greenwich LifeSciences, Inc. Stock... sign in my perfect resume
GLSI Stock News GREENWICH LIFESCIENCES Stock Price Today
WebGreenwich LifeSciences, Inc. (GLSI) Stock Price, News, Quote & History - Yahoo Finance S&P 500 Dow 30 Nasdaq Russell 2000 (+0.13%) Crude Oil -0.24(-0.30%) Gold … WebGreenwich LifeSciences (GLSI) Stock Forecast, Price Targets and Analysts Predictions - TipRanks.com Greenwich LifeSciences Stock forecast & analyst price target predictions based on 1 analysts offering 12-months price targets for GLSI in the last 3 months. Top Stocks Top Analyst StocksTop Smart Score StocksTop Insiders Stocks Popular WebApr 10, 2024 · Stock Price Forecast According to 7 stock analysts, the average 12-month stock price forecast for GLSI stock is $ 79.56 , which predicts an increase of 556.44%. The lowest target is $ 78.78 and the highest is $ 81.9. On average, analysts rate GLSI stock as a buy. Analyst Consensus: Buy Analyst Ratings sign in my snhu